News Archives for Luxturna

Recent News

ASGCT Announces 2018 Award Winners

Drs. Jean Bennett (Outstanding Achievement), Luk Vandenberghe (Outstanding New Investigator), Luca Biasco (Outstanding New Investigator), and Francesca Pasinelli (Sonia Skarlatos Public Service) will be recognized for their tremendous contributions to gene and cell therapy at ASGCT’s 21st Annual Meeting.

ASGCT Celebrates FDA Approval of Voretigene Neparvovec (Luxturna) as Treatment for Inherited Retinal Disease
December 19, 2017
Gene Therapy Approval Luxturna

Groundbreaking gene therapy is the first AAV viral vector product to be approved for use in the United States.

2019
ASGCT Policy Summit
November 4 – 6 | Washington D.C.
Close